adjuvants, immunologic

Preferred Label : adjuvants, immunologic;

MeSH definition : Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity.;

MeSH synonym : immunostimulants; immunologic adjuvants; immunological adjuvants; immunological adjuvant; immunologic adjuvant; adjuvant, immunological; immunopotentiators; adjuvant, immunologic; adjuvants, immunological; immunoadjuvants; immunoactivators; Immunostimulant; Immunopotentiator; Immunoadjuvant;

MeSH annotation : DF: ADJUVANTS IMMUNOL;

Wikipedia link : https://en.wikipedia.org/wiki/Adjuvants, immunologic;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D000276;

UMLS CUI

C0001551;

ATC code(s)
- immunostimulants [ATC Code]
ATC code(s)
- colony stimulating factors [ATC Code]
- histamine dihydrochloride [ATC Code]
- immunostimulants [ATC Code]
- interferons [ATC Code]
- interleukins [ATC Code]
- other immunostimulants [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- biosynthesis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- deficiency [MeSH Qualifier]
- economics [MeSH Qualifier]
- genetics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- physiology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Immune enhancement agent (product) [SNOMED CT concept]
- Immunologic adjuvant (substance) [SNOMED CT concept]
- Immunopotency, function (observable entity) [SNOMED CT concept]
- Immunostimulant [NCIt concept]
- Immunostimulants [ICD-11 Extension code]
- Immunotherapeutic Agent [NCIt concept]
- immunopotency [SNOMED Notion]
- immunostimulants [ATC Code]
- immunostimulants [ATC Code]
- other immunostimulants [ATC Code]
CISMeF manual mappings
- Immunostimulant poisoning (disorder) [SNOMED CT concept]
Currated CISMeF NLP mapping
- Immunoadjuvant [NCIt concept]
Indexing information
- 1,2,3-tris(1-((2,3,4,6-tetra-O-acetyl-beta-D-mannopyranosyl)-(1-2)-(3,4,6-tri-O-acetyl-alpha-D-mannopyranosyloxyethyl))-4-(methyl-1-oxy)-1,2,3-triazolyl)propane [MeSH Supplementary Concept]
- 6,6'-bis-O-(3-nonyldodecanoyl)-alpha,alpha'-trehalose [MeSH Supplementary Concept]
- APS-1 polysaccharide sulfate [MeSH Supplementary Concept]
- ARI-4175 [MeSH Supplementary Concept]
- ASO2A adjuvant [MeSH Supplementary Concept]
- CRL 1005 [MeSH Supplementary Concept]
- Cia25 protein, rat [MeSH Supplementary Concept]
- IRS 19 [MeSH Supplementary Concept]
- ISCOMATRIX [MeSH Supplementary Concept]
- Leflunomide [MeSH Descriptor]
- QB 90U [MeSH Supplementary Concept]
- SBAS4 adjuvant system [MeSH Supplementary Concept]
- adjuvant SBAS-2 [MeSH Supplementary Concept]
- apilarnil [MeSH Supplementary Concept]
- astragaloside VII [MeSH Supplementary Concept]
- biphasix-vaccine targeting adjuvant [MeSH Supplementary Concept]
- bupleuran 2IIc [MeSH Supplementary Concept]
- cysteinyl-lysyl-aspartyl-valyl-tyrosine [MeSH Supplementary Concept]
- decapeptide B 2702 [MeSH Supplementary Concept]
- delta inulin [MeSH Supplementary Concept]
- focetria [MeSH Supplementary Concept]
- fruglumin [MeSH Supplementary Concept]
- hunter's adjuvant [MeSH Supplementary Concept]
- immune no. 2 [MeSH Supplementary Concept]
- incomplete freund's adjuvant [MeSH Supplementary Concept]
- macrophyllosaponin B [MeSH Supplementary Concept]
- ribi adjuvant [MeSH Supplementary Concept]
- starch-acrylamide polymer [MeSH Supplementary Concept]
- syntex adjuvant formulation [MeSH Supplementary Concept]
- virulizin [MeSH Supplementary Concept]
Record concept(s)
- adjuvants, immunologic [MeSH concept]
SNOMED CT : is a
- interferons [MeSH Descriptor]
- levamisole [MeSH Descriptor]
See also
- adjuvants, pharmaceutic [MeSH Descriptor]
See also inter- (CISMeF)
- Immunopotentiation [NCIt concept]
Semantic type(s)
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 1018 oligonucleotide [MeSH Supplementary Concept]
- 3-(2,2,2-trimethylhydrazine)propionate [MeSH Supplementary Concept]
- 5-hydroxymethyluracil [MeSH Supplementary Concept]
- 6-methyluracil [MeSH Supplementary Concept]
- 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester [MeSH Supplementary Concept]
- 8-hydroxyguanosine [MeSH Supplementary Concept]
- 8-thioguanosine [MeSH Supplementary Concept]
- BCG vaccine [MeSH Descriptor]
- Broncho-Vaxom [MeSH Supplementary Concept]
- CPG-oligonucleotide [MeSH Supplementary Concept]
- Endocine [MeSH Supplementary Concept]
- FK 156 [MeSH Supplementary Concept]
- GLA 60 [MeSH Supplementary Concept]
- Glatiramer Acetate [MeSH Descriptor]
- ISCOMs [MeSH Descriptor]
- Imiquimod [MeSH Descriptor]
- Interferon beta-1a [MeSH Descriptor]
- Interferon beta-1b [MeSH Descriptor]
- Interleukin-12 [MeSH Descriptor]
- Interleukin-4 [MeSH Descriptor]
- KRN 7000 [MeSH Supplementary Concept]
- Lenograstim [MeSH Descriptor]
- MEDI9197 [MeSH Supplementary Concept]
- MF59 oil emulsion [MeSH Supplementary Concept]
- Monatide (IMS 3015) [MeSH Supplementary Concept]
- N-acetyl-beta-glucosaminyl-N-acetylmuramyl-alanylisoglutamine [MeSH Supplementary Concept]
- NPT 15392 [MeSH Supplementary Concept]
- OM 89 [MeSH Supplementary Concept]
- Ribomunyl [MeSH Supplementary Concept]
- SK&F 105685 [MeSH Supplementary Concept]
- SolcoTrichovac [MeSH Supplementary Concept]
- T-activin [MeSH Supplementary Concept]
- Thymalfasin [MeSH Descriptor]
- TraT protein, E coli [MeSH Supplementary Concept]
- acemannan [MeSH Supplementary Concept]
- acetylmuramyl-alanyl-isoglutamine [MeSH Descriptor]
- aclacinomycins [MeSH Supplementary Concept]
- aconitine [MeSH Descriptor]
- algammulin [MeSH Supplementary Concept]
- aluminum hydroxide [MeSH Descriptor]
- aluminum phosphate [MeSH Supplementary Concept]
- aluminum sulfate [MeSH Supplementary Concept]
- amiprilose [MeSH Supplementary Concept]
- ammonium trichloro(dioxoethylene-O,O'-)tellurate [MeSH Supplementary Concept]
- amylase, phosphates, proteases drug combinations [MeSH Supplementary Concept]
- avridine [MeSH Supplementary Concept]
- azimexon [MeSH Supplementary Concept]
- bemethyl [MeSH Supplementary Concept]
- bendazole [MeSH Supplementary Concept]
- benphothiamine [MeSH Supplementary Concept]
- beta-1,3-glucan [MeSH Supplementary Concept]
- bromantane [MeSH Supplementary Concept]
- bropirimine [MeSH Supplementary Concept]
- brucine [MeSH Supplementary Concept]
- bryostatin 1 [MeSH Supplementary Concept]
- carbidopa, levodopa drug combination [MeSH Supplementary Concept]
- carboxyimamidate [MeSH Supplementary Concept]
- cell wall skeleton [MeSH Descriptor]
- cholera toxin [MeSH Descriptor]
- ciamexon [MeSH Supplementary Concept]
- colforsin [MeSH Descriptor]
- cord factors [MeSH Descriptor]
- dehydroepiandrosterone [MeSH Descriptor]
- detox adjuvant [MeSH Supplementary Concept]
- dimephosphon [MeSH Supplementary Concept]
- dimethyldioctadecylammonium [MeSH Supplementary Concept]
- ditiocarb [MeSH Descriptor]
- diucifon [MeSH Supplementary Concept]
- edrecolomab [MeSH Supplementary Concept]
- enkephalin-Leu, Ala(2)-Arg(6)- [MeSH Supplementary Concept]
- essential 303 forte [MeSH Supplementary Concept]
- feline leukemia virus vaccine [MeSH Supplementary Concept]
- flavone acetic acid [MeSH Supplementary Concept]
- flt3 ligand protein [MeSH Supplementary Concept]
- forphenicinol [MeSH Supplementary Concept]
- freund's adjuvant [MeSH Descriptor]
- glucosaminylmuramyl-2-alanine-D-isoglutamine [MeSH Supplementary Concept]
- glycoprotein, klebsiella pneumoniae [MeSH Supplementary Concept]
- grifolan [MeSH Supplementary Concept]
- hemodes [MeSH Supplementary Concept]
- heptanoyl-gamma-D-glutamyl-L-meso-diaminopimelyl-D-alanine [MeSH Supplementary Concept]
- hyaluronic acid [MeSH Descriptor]
- immunoferon [MeSH Supplementary Concept]
- inosine pranobex [MeSH Descriptor]
- insecticidal crystal protein, bacillus thuringiensis [MeSH Supplementary Concept]
- interleukin-24 [MeSH Supplementary Concept]
- jacalin [MeSH Supplementary Concept]
- keyhole-limpet hemocyanin [MeSH Supplementary Concept]
- lentinan [MeSH Descriptor]
- leukinferon [MeSH Supplementary Concept]
- levamisole [MeSH Descriptor]
- lisofylline [MeSH Supplementary Concept]
- lithium chloride [MeSH Descriptor]
- lobenzarit [MeSH Supplementary Concept]
- mafosfamide [MeSH Supplementary Concept]
- metanil yellow [MeSH Supplementary Concept]
- methanol extraction residue (MER) tubercle bacillus fraction [MeSH Supplementary Concept]
- mifamurtide [MeSH Supplementary Concept]
- monophosphoryl lipid A [MeSH Supplementary Concept]
- montanide ISA 50 V [MeSH Supplementary Concept]
- montanide ISA 761 VG [MeSH Supplementary Concept]
- montanide ISA 763A VG [MeSH Supplementary Concept]
- montanide ISA-201 [MeSH Supplementary Concept]
- murabutide [MeSH Supplementary Concept]
- myelopeptides [MeSH Supplementary Concept]
- neurotropin [MeSH Supplementary Concept]
- octamethylcyclotetrasiloxane [MeSH Supplementary Concept]
- osthol [MeSH Supplementary Concept]
- oxazolone [MeSH Descriptor]
- pancreatic extract, povidone drug combination [MeSH Supplementary Concept]
- phenazepam [MeSH Supplementary Concept]
- pidotimod [MeSH Supplementary Concept]
- plumbagin [MeSH Supplementary Concept]
- poly A-U [MeSH Descriptor]
- poly-1-6-glucopyranosyl-1-3-glucopyranose glucan [MeSH Supplementary Concept]
- polysaccharide-K [MeSH Supplementary Concept]
- prodigiozan [MeSH Descriptor]
- pycnogenols [MeSH Supplementary Concept]
- pyrogenal [MeSH Supplementary Concept]
- quil A [MeSH Supplementary Concept]
- retinol acetate [MeSH Supplementary Concept]
- ribosome inactivating protein, Viscum [MeSH Supplementary Concept]
- romurtide [MeSH Supplementary Concept]
- roquinimex [MeSH Supplementary Concept]
- salmozan [MeSH Supplementary Concept]
- saponin QA-21V1 [MeSH Supplementary Concept]
- sizofiran [MeSH Descriptor]
- sodium nucleinate [MeSH Supplementary Concept]
- specific substance maruyama [MeSH Supplementary Concept]
- squaric acid dibutyl ester [MeSH Supplementary Concept]
- swainsonine [MeSH Descriptor]
- thymalin [MeSH Supplementary Concept]
- thymic humoral factor gamma 2 [MeSH Supplementary Concept]
- thymogen [MeSH Supplementary Concept]
- thymopentin [MeSH Descriptor]
- thymopoietin III [MeSH Supplementary Concept]
- thymostimulin [MeSH Supplementary Concept]
- tolpa [MeSH Supplementary Concept]
- ubenimex [MeSH Supplementary Concept]
- ukrain [MeSH Supplementary Concept]
- unlipidated outer membrane protein 19, Brucella [MeSH Supplementary Concept]
- vesnarinone [MeSH Supplementary Concept]
- wobenzym [MeSH Supplementary Concept]
- xymedon [MeSH Supplementary Concept]
UMLS correspondences (same concept)
- Immune enhancement agent (product) [SNOMED CT concept]
- Immune enhancement agent (substance) [SNOMED CT concept]
- Immunoadjuvant [NCIt concept]
- Immunologic adjuvant (substance) [SNOMED CT concept]
- Immunostimulant [NCIt concept]
- adjuvant, nos [SNOMED Notion]
- immune enhancement agent, nos [SNOMED Notion]
- immunostimulants [ATC Code]
- immunostimulants [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients